Hints and tips:
Related Special Reports
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
AustralianSuper’s stake in Vantage Data Centers reflects shift from struggling property sector to digital frontier
...The case is the latest in a series of intellectual property battles that companies are fighting around the world over mRNA technology, which has helped generate billions in revenues for the pharmaceuticals...
A company launched in 1963 confronts challenge of adapting to the rise of anti-obesity injections
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
US healthcare company is putting cash to work from spinning off its consumer health arm
Shah Capital wants change in US biotech’s strategy as its shares have tumbled since their pandemic peak
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
A weight loss titan fights to stay relevant in the age of GLP-1 drugs
Advocate general of bloc’s top court says decision against world’s biggest gene sequencing group should be annulled
...Paying for everyday transactions with a tap, swipe or click of a card or phone is convenient. But it is not cost-free....
...Pharmaceuticals groups Pfizer and Moderna, which have both faced criticism from fringe groups over their Covid-19 vaccines, also spent heavily on security for their CEOs last year....
.... ©2023 Nikkei Inc. All rights reserved....
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
...German pharmaceutical glassware company Schott Pharma should receive a warm reception when it joins the Frankfurt Stock Exchange later this year....
US drugmaker is trying to chart its future without blockbuster Covid-19 products
...Despite splashing out nearly $55bn on two major acquisitions over the past two years, the pharmaceutical company is worth less than it was before the pandemic....
...Beyond the cash cow, the genre taps into the increasing draw of such theories amid growing mistrust in governments, and the mainstreaming of conspiratorial narratives in recent years, she says....
...Meanwhile, Uber seems to be turning on the taps in its ride-hailing division....
...More people are opting to pay with a click or tap of their phones. Apple, by way of the iPhone, has been at the forefront of this trend....
Millions of Paxlovid pills have gone unused as tight controls restrict access
...Rival pharmaceutical groups are eager to enter the market, including AstraZeneca, which recently signed a licensing deal with Chinese company Eccogene for the rights to its weight loss pill....
Doubts grow over safety and effectiveness of drugs that were marketed as coronavirus treatments
...EU manufacturing is heavily reliant on imported active pharmaceutical ingredients from China and India....
...The complaint accuses the company of abusing its market power in a variety of ways: to squash the growth of innovative apps and messaging services, reduce the appeal of rival smartwatches, keep rival tap-and-pay...
International Edition